AI in Healthcare

The latest on artificial intelligence transforming medicine

News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.

Filtered by: digital biomarkersClear filter
researchNewswise

Can AI and Wearables Finally Fix the Broken Pain Scale?

A new JMIR report highlighted by Newswise asks whether AI and wearable sensors can replace or augment the notoriously subjective pain scale. The idea is compelling because pain remains one of medicine’s most important symptoms and one of its least precisely measured.

painwearablesmeasurementdigital biomarkers
research

What the Evidence Really Says About AI Mental Health Monitoring

Telehealth.org takes a close look at the evidence behind AI-based mental health monitoring, an area attracting growing interest from payers, employers, and digital health vendors. The key question is whether passive monitoring can detect risk early without creating false reassurance, noise, or privacy backlash.

Telehealth.org
mental healthmonitoringdigital biomarkers
clinical

Noah Labs’ Breakthrough Designation Tests the Promise of Voice as a Cardiac Biomarker

Noah Labs has received FDA breakthrough device designation for an AI system that uses voice signals to monitor heart failure. The decision highlights growing regulatory openness to nontraditional digital biomarkers, while leaving the harder questions of clinical utility, workflow integration, and reimbursement still to be answered.

Medical Device Network
heart failuredigital biomarkersvoice AI
regulation

FDA Breakthrough nod for voice AI suggests heart failure screening is moving beyond imaging

Noah Labs’ breakthrough designation for a voice-based AI tool to detect heart failure signals growing FDA interest in nontraditional biomarkers. The development matters less as a single company milestone than as evidence that speech may become a clinically useful front door for cardiovascular screening and monitoring.

MassDevice
FDAbreakthrough designationheart failure
research

Wearables Gain Ground as Parkinson’s Trials Search for Better, More Continuous Endpoints

Wearables are being used to track Parkinson’s symptoms in Annovis’s drug study, adding to momentum behind digital biomarkers in neurodegenerative research. The approach could make trials more sensitive to day-to-day changes that clinic visits often miss, though validation remains the key hurdle.

Stock Titan
Parkinson's diseasewearablesdigital biomarkers

How this works

Discover

An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.

Structure

The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.

Publish

Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.